trending Market Intelligence /marketintelligence/en/news-insights/trending/ohsxxxdosp4xlyljqa7waw2 content esgSubNav
In This List

Cell MedX appoints board member to add medical device experience

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Cell MedX appoints board member to add medical device experience

Carson City, Nev.-based Cell MedX Corp. added George Adams to its board of directors.

Adams was previously CEO of Amorfix Life Sciences, which is known as ProMIS Neurosciences Inc.

The healthcare equipment company said Adams is experienced in bringing medical devices to global markets. Cell MedX develops medical devices for high blood pressure, diabetes and Parkinson's disease.